Blood Cancer Talks

1. How I Approach Smoldering Myeloma (Vaxman and Gertz):
2. Risk-Stratification Models in SMM:
Mayo 2018 model:
PETHEMA (Spanish) model:
PANGEA model:
IMWG SMM model:
3. QuiRedex RCT (Lenalidomide-Dexamethasone vs Observation in High-Risk SMM):
4. ECOG E3A06 RCT (Lenalidomide vs Observation in SMM):
5. Intensive Treatment in High-Risk Smoldering Multiple Myeloma:
6. Current Clinical Trial Landscape in Smoldering Myeloma:
7. How Light Chain Proteinuria Modulates Risk of Progression in Patients with sFLC ratio>100 as the only Myeloma-Defining Event?

What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk